Am J Physiol Heart Circ Physiol 292: H483-H495, 2007.
First published September 8, 2006; doi:10.1152/ajpheart.00632.2006
0363-6135/07 $8.00
Autocrine/paracrine pattern of superoxide production through NAD(P)H oxidase in coronary arterial myocytes
Guo Zhang,1,3
Fan Zhang,1
Rachel Muh,1
Fan Yi,1
Karel Chalupsky,2
Hua Cai,2 and
Pin-Lan Li1
1Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia; 2Section of Cardiology, Department of Medicine, Division of Biological Sciences and Pritzker School of Medicine, University of Chicago, Chicago, Illinois; 3 Research Center of Experimental Medicine, Guangxi Autonomous Region People's Hospital, Nanning, Guangxi, People's Republic of China
Submitted 14 June 2006
; accepted in final form 31 August 2006
 |
ABSTRACT
|
|---|
The present study tested the hypothesis that membrane-bound NAD(P)H oxidase in coronary arterial myocytes (CAMs) is capable of producing superoxide (O2
) toward extracellular space to exert an autocrine- or paracrine-like action in these cells. Using a high-speed wavelength-switching fluorescent microscopic imaging technique, we simultaneously monitored the binding of dihydroethidium-oxidizing product to exogenous salmon testes DNA trapped outside CAMs and to nuclear DNA as indicators of extra- and intracellular O2
production. It was found that a muscarinic agonist oxotremorine (OXO; 80 µM) increased O2
levels more rapidly outside than inside CAMs. In the presence of superoxide dismutase (500 U/ml) plus catalase (400 U/ml) and NAD(P)H oxidase inhibitor diphenylene iodonium (50 µM) or apocynin (100 µM), these increases in extra- and intracellular O2
levels were substantially abolished or attenuated. The O2
increase outside CAMs was also confirmed by detecting oxidation of nitro blue tetrazolium and confocal microscopic localization of Matrigel-trapped OxyBURST H2HFF Green BSA staining around these cells. By electron spin resonance spectrometry, the extracellular accumulation of O2
was demonstrated as a superoxide dismutase-sensitive component outside CAMs. Furthermore, RNA interference of NAD(P)H oxidase subunits Nox1 or p47 markedly blocked OXO-induced increases in both extra- and intracellular O2
levels, whereas small inhibitory RNA of Nox4 only attenuated intracellular O2
accumulation. These results suggest that Nox1 represents a major NAD(P)H oxidase isoform responsible for extracellular O2
production. This rapid extracellular production of O2
seems to be unique to OXO-induced M1-receptor activation, since ANG II-induced intra- and extracellular O2
increases in parallel. It is concluded that the outward production of O2
via NAD(P)H oxidase in CAMs may represent an important producing pattern for its autocrine or paracrine actions.
reactive oxygen species; redox signaling; artery
SINCE THE 1970s, many studies have documented that, in the presence of an exogenous superoxide (O2
) donor, the action of endothelium-dependent relaxing factors could be attenuated and vasoconstriction occurred. When superoxide dismutase (SOD) was used to pretreat the arteries, this exogenous O2
-induced vasoconstriction or impairment of vasodilation was significantly attenuated (26, 32). In this regard, Furchgott and colleagues (22, 34) further demonstrated that addition of SOD in the bath solution of the arterial preparations to dismutate O2
significantly enhanced endothelium-dependent vasodilation and increased the bioavailability of one of the endothelium-dependent relaxing factors, nitric oxide (NO). Given that SOD was added outside vascular cells in these experiments, it seems that an interaction of O2
and NO would occur in the extracellular compartment or interstitial space because SOD as a protein cannot easily enter the cells. Even polyethylene glycol-SOD as used in some experiments (3, 21) may only facilitate approaches of SOD to the cell membrane in acute or short-term experimental protocols, rather than the entry of SOD into the cells. This raises several questions over the resources of O2
outside vascular cells and the precise working location of extracellular O2
in the vasculature. For example, where are O2
anions outside vascular cells derived from? Are extracellular O2
anions actively produced outward by vascular cells or passively spilled over? How could this extracellular O2
production be controlled under physiological conditions? Although there are some reports indicating that vascular endothelial cells may release O2
or hydrogen peroxide (H2O2) toward their surrounding space (16, 23), these questions are far from solved.
It has become clearer and clearer that there are several potential enzymatic sources of O2
in the cardiovascular system, such as xanthine oxidase, mitochondrial respiratory chain arachidonic acid metabolizing system, uncoupled NO synthase, and NAD(P)H oxidase (43, 46). There is increasing evidence that NAD(P)H oxidase is a major source of O2
in vascular cells (16, 35, 52) and that NAD(P)H oxidase-derived O2
serves as an important physiological redox signaling molecule to participate in the regulation of vascular function. In vascular smooth muscle cells (VSMCs), recent studies have reported that there are membrane-bound and intracellular nonmitochondrial NAD(P)H oxidases, which are all capable of producing O2
in these cells (5, 16). With various existing techniques, O2
has been demonstrated to be accumulated within VSMCs when NAD(P)H oxidase is activated by different agonists such as ANG II (15). This intracellular accumulation of O2
led to an assumption that a plasma membrane-bound NAD(P)H oxidase may produce and release O2
into cells, which is different from the orientation of phagocyte NAD(P)H oxidases (16). However, the proposed topology of NAD(P)H oxidase subunits indicates that membrane-associated NAD(P)H oxidase should not release O2
into cytosol (4, 25). Studies on subcellular localization of vascular NAD(P)H oxidase subunits also demonstrated that O2
within VSMCs may not be derived from plasma membrane NAD(P)H oxidase but rather from intracellular compartmental NAD(P)H oxidase (45, 52). More recently, using patch-clamp technique, our group (30) surprisingly recorded an inward current associated with NAD(P)H oxidase in coronary arterial myocytes (CAMs) that was similar to that recorded in phagocytes, indicating that an outward electron flow and O2
production occurred in these VSMCs. It seems that a membrane-bound NAD(P)H oxidase in VSMCs could generate O2
toward the outside of these cells, and in this way O2
may exert regulatory roles as an autocrine or paracrine.
To test this hypothesis, we first modified a high-speed wavelength-switching fluorescent microscopic imaging technique to allow a simultaneous monitoring of extracellular and intracellular O2
production in single CAMs. In addition to the intracellular DNA trapping of dihydroethidium (DHE) product, a Matrigel DNA trapping around CAMs was developed to detect O2
-oxidized DHE signals, which represents extracellular O2
levels. In addition, O2
-mediated precipitation from nitro blue tetrazolium (NBT) and Matrigel-trapped OxyBURST H2HFF Green BSA staining around CAMs were also determined by light or confocal fluorescent microscopy, respectively. Using electron spin resonance (ESR) spectrometric measurement, we examined whether SOD-sensitive extracellular O2
changes could be detected. After we confirmed the extracellular production of O2
in response to activation of M1-muscarinic receptor, we observed the effects of O2
scavengers or specific NAD(P)H oxidase inhibitors on intracellular and extracellular O2
production and also dissected the contribution of different NAD(P)H oxidase isoforms to this agonist-induced redox response by RNA interference with specific, small inhibitory RNAs (siRNAs). We then went on to examine whether O2
outward production in response to M1-muscarinic activation occurs when CAMs were stimulated by other agonists, in particular ANG II. Our results suggest that activation of NAD(P)H oxidase gives rise to a different spatiotemporal pattern of O2
production when these cells are exposed to different stimuli. Most importantly, our experiments provide direct evidence at the single cell level that the outward production of O2
associated with NAD(P)H oxidase occurs in CAMs, which may exert autocrine or paracrine actions in the redox regulation of vascular function.
 |
MATERIALS AND METHODS
|
|---|
Isolation and culture of CAMs.
As our group described previously (41), fresh bovine hearts were obtained from a local abattoir, and intramyocardial coronary arteries from the branches of left anterior descending artery were rapidly dissected. Endothelium-denuded coronary arteries were rinsed with medium 199 containing 5% FBS, a 2% solution of antibiotics (penicillin-streptomycin), 0.3% gentamicin, and 0.3% nystatin and cleaned of connective tissues. After they were cut into small pieces, the arteries were placed into dishes with the lumen side down and incubated in medium 199 containing 10% FBS, 1% glutamine, 1% antibiotic solution, 0.3% gentamicin, 0.3% nystatin, and 0.1% tylosin for 35 days until vascular myocytes migrated to the dishes. Once CAM growth had been established, the vessels were removed, and the cells were grown in medium 199 containing 20% FBS. All cells were maintained in an incubator with 5% CO2 in air at 37°C. The CAMs were identified by positive staining with an anti-
-actin antibody. All studies were performed with cells of passages 24.
Simultaneously monitoring O2
production inside and outside CAMs.
This method is based on the DNA binding characteristic of oxidized DHE product ethidium in intracellular DNA and Matrigel-trapped extracellular DNA when CAMs were stimulated by different agonists. This DNA binding assay of O2
, which oxidizes DHE to produce a strong red fluorescence, is widely used for intracellular O2
production in the vessel wall and in isolated vascular endothelial and VSMCs (6, 40). However, this DNA-ethidium binding assay has not yet been used to detect extracellular O2
at the single cell level. The major challenge is how to trap DNA outside the cells. To solve this problem, we have used Matrigel (BD Biosciences) as a supportive matrix to trap DNA that is capable of binding to the ethidium from oxidation of DHE in solution. In these experiments, isolated CAMs (102 cells/well) were seeded into a 16-well chamber slide with a transparent glass bottom (LAB-TEK) and incubated overnight to attach the bottom of the wells. On the day of experiments, the culture medium was first discarded, CAMs were washed twice with Hanks buffer, and 40 µl of salmon testes DNA solution (7.5 mg/ml; Sigma) were mixed with 40 µl of Matrigel solution (at 4°C) and then were carefully loaded onto the top of CAMs. After 5 min at room temperature, the gel was polymerized and exogenous DNA was immobilized around these cells. The CAMs with Matrigel were then filled with Hanks buffer containing 250 µM DHE. After a 60-min loading of DHE into the CAMs, the chamber slide was mounted on the stage of a fluorescent microscope that we routinely used for high-speed wavelength-switching imaging acquisition and recording. For both intracellular and extracellular DHE oxidizing signals, a ratio of ethidium-DNA to DHE signals was recorded (ethidium-DNA fluorescence signal was detected at an excitation of 480 nm and an emission of 610 nm, and DHE fluorescence signal was detected at an excitation of 380 nm and an emission of 445 nm). For each experiment, 810 CAMs were monitored simultaneously and an average value was used for statistical analysis.
The M1-receptor agonist oxotremorine (OXO; 80 µM) was added to activate its receptor and consequently stimulate O2
production. In the groups of CAMs receiving O2
scavengers or NAD(P)H oxidase inhibitors, SOD (500 U/ml) plus catalase (400 U/ml), diphenylene iodonium (DPI; 50 µM), or apocynin (100 µM) was preincubated with the cells for 15 min, and then the O2
-producing response to OXO was determined. In addition, a time course of NAD(P)H oxidase activation and intracellular and extracellular O2
production in response to ANG II was monitored, when this peptide was added into the well containing Matrigel and cells at a concentration of 100 nM. All doses of these agonists or inhibitors used in the present experiments were based on previous studies reported by our laboratory and other laboratories.
NBT precipitation detection of extracellular O2
.
As described in previous studies (13), O2
accumulation outside CAMs was also determined with NBT, which reacts with O2
and produces a blue formazin precipitate. NBT (0.1%) was prepared in PBS by adding 10 mg of NBT powder (Sigma) to 100 ml of PBS (pH 7.2) and stirred at room temperature for 1 h. NBT staining was then performed by adding 0.1% of NBT solution into a well seeded with CAMs and incubated for 30 min at 37°C before and after addition of OXO (80 µM). Under x100 magnification microscopy (Nikon), two-dimensional optical images were acquired with a digital camera (Spot).
Confocal microscopic detection of extracellular O2
.
To further determine extracellular O2
, CAMs were prepared as described above for ethidium-DNA trapping imaging. In brief, 0.5 ml of Matrigel was mixed with 25 µl of OxyBURST H2HFF Green BSA (10 µg/ml; Molecular Probes) and then used to evenly coat the 35 mm x 10-mm cell culture dish. Freshly isolated CAM suspension (60 µl) was loaded on the top of the ice-cold Matrigel matrix, and then the culture dish was gently tapped three or four times to sit cells on the surface of the gel. At room temperature, the gel was polymerized in
5 min. Then, 2 ml of Krebs-Ringer phosphate buffer, which contains PBS, pH 7.4, with 1.0 mM Ca2+, 1.5 mM Mg2+, and 5.5 mM glucose, were added. Confocal fluorescent microscopic images were acquired by an Olympus Fluoview system (version 4.2, FV300), consisting of an Olympus BX61WI inverted microscope with an Olympus Lumplan F1 x60, 0.9 numerical aperture, water-immersion objective. A single z-section was taken, or 0.1-µm sections were obtained through the cell with excitation and emission wavelengths of 488 and 530 nm, respectively, for OxyBURST. Real-time microscopic fluorescence images were acquired every 1 or 2 min under control conditions and after different treatments. This OxyBURST H2HFF Green BSA detects H2O2, which mirrors O2
production outside the cells because BSA cannot enter the cells (8).
ESR detection of extracellular O2
.
For extracellular O2
assay, gently collected CAMs were suspended in modified Krebs-HEPES buffer containing deferoxamine (100 µM; metal chelator). Approximately 1 x 106 cells were then incubated with OXO (80 µM) or ANG II (100 nM) for 30 min; these were subsequently mixed with 1 mM of the O2
-specific spin trap 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH) in the presence or absence of manganese-dependent SOD (500 U/ml). The cell mixture was then loaded in glass capillaries and immediately kinetically analyzed for O2
production for 10 min. The SOD-inhibitable fraction of the signal was compared. The ESR settings were as follows: biofield, 3,350; field sweep, 60 G; microwave frequency, 9.78 GHz; microwave power, 20 mW; modulation amplitude, 3 G; 4,096 points of resolution; receiver gain, 100; and kinetic time, 10 min (7).
RNA interference and Nox1, Nox4, and p47phox gene in CAMs.
To dissect the role of different NAD(P)H oxidase subunits in OXO-induced or ANG II-induced O2
production outside or inside CAMs, RNA interference was performed to silence the gene coding these subunits. Three pairs of siRNAs were designed and targeted, including p47 (AAAGGGCTCGAGTTCCCAAAT), Nox1 (AAGGGCTTTCGAACAACAATA), Nox4 (AAGACCTGGCCAGTATATTAT), and Nox2 (AAGTCGGTCTGGTACAAATAT). Selection of these NAD(P)H oxidase subunits was based on previous studies that indicated that these may contribute to the activity of membrane-bound and cytosolic compartmental components of NAD(P)H oxidases (20, 45). In these experiments, siRNA transfection was performed according to the manufacturer's instruction in Qiagen TransMessenger kit. All siRNAs were chosen with a Qiagen siRNA design program and synthesized and double-stranded by Xeragon. A scrambled, small RNA was synthesized for a negative control.
Statistics.
Data are expressed as means ± SE. The significance of the differences in mean values between and within multiple groups such as multiple time points was examined by ANOVA for repeated measures followed by Duncan's multiple range test. Student's t-test was used to evaluate the statistical significance of differences between two paired observations. P < 0.05 was considered statistically significant.
 |
RESULTS
|
|---|
Spatiotemporal pattern of O2
production by CAMs in response to OXO.
Using the high-speed wavelength-switching technique, we simultaneously monitored the fluorescence intensity of ethidium-DNA complex within primary cultures of CAMs and in Matrigel around these cells. Figure 1A shows typical fluorescent images acquired during 30 min when a CAM received OXO at a concentration of 80 µM. It was found that, at the first 10 min of incubation with OXO, O2
levels increased with a predominate response outside cells (becoming red). Starting at 15 min of OXO incubation, intracellular fluorescence intensity increased when the outside signal became much stronger. At
30 min of OXO incubation, intracellular fluorescence became as intense as those observed outside cells. This dynamic change in intracellular and extracellular ethidium-DNA fluorescence was digitized and acquired by using a MetaFluor program (version 6.2). Summarized results are presented in Fig. 1B. It was clear that OXO produced a more rapid increase in ethidium-DNA fluorescence outside CAMs than inside these cells. At 30 min of OXO incubation, the intracellular signal reached a level similar to that observed outside CAMs. In addition, we also monitored similar changes in dynamic responses of intracellular and extracellular ethidium-DNA fluorescence in freshly isolated CAMs in response to OXO (data not shown).
In the presence of SOD (500 U/ml) in the chamber solution, OXO-induced increases in O2
levels both inside and outside CAMs were completely blocked (remained blue, as shown in Fig. 1A). As summarized in Fig. 1C, O2
increases induced by OXO both outside and inside CAMs were blocked by extracellular SOD + CAT (400 U/ml), but not by CAT alone, suggesting that these signals are specific to O2
production. It should be noted that the blockade of intracellular O2
production by extracellular SOD in this preparation may be associated with a triggering or activating action of O2
on intracellular NAD(P)H oxidase through different pathways such as PKC and ion channels (19, 42). Therefore, when SOD dismutates O2
outside CAMs, this activation of intracellular NAD(P)H oxidase was simultaneously blocked.
To address a concern regarding whether a rapid increase in extracellular fluorescent signal in response to OXO stimulation may be due to the different speeds of ethidium binding to intracellular DNA or extracellular DNA in Matrigel, we performed a similar recording with substitution of intracellular 2',7'-dichlorofluorescin diacetate (H2DCFDA, a cell-permeant indicator for reactive oxygen species) for DHE, where H2DCFDA in cytosol directly reacts with H2O2. The results showed a similar pattern of intracellular and extracellular changes in O2
production in response to OXO (data not shown), where the extracellular increase in fluorescent signal was more rapid than the intracellular increase.
NBT precipitation.
As shown in Fig. 2A, using NBT staining, we found that dark blue precipitations were significantly increased when CAMs were incubated with OXO. These experiments were performed to further confirm an extracellular production of O2
. As mentioned above, NBT in the bath solution could be reduced by reactive oxygen species (ROS) to dark blue, insoluble formazin-NBT, producing dark blue particles outside the cells. This dye is widely used to detect activation of NAD(P)H oxidase in different cells (12, 18). Although NBT may not be used to specifically dissect which ROS molecules are produced outside CAMs, when it was reduced and precipitated in these experiments, it is indicative for O2
production under these conditions.
Confocal microscopic detection of extracellular OxyBURST Green H2HFF BSA.
Another approach that we used to further detect extracellular O2
levels is confocal microscopic analysis of OxyBURST Green H2HFF BSA. This BSA-conjugated fluorescent dye is primarily used to detect extracellular ROS by illustrating H2O2. Because BSA cannot enter cells, the detected green fluorescence in Matrigel around CAMs represents extracellular ROS. Although it might not detect O2
, this fluorescence intensity reflects O2
-derived ROS levels. As shown in Fig. 2B, OXO markedly increased green fluorescence in Matrigel containing OxyBURST Green H2HFF BSA, which was blocked completely by SOD and catalase.
ESR measurements of extracellular O2
levels.
Using ESR spectrometric assay, we demonstrated the O2
production and release from CAMs in response to OXO. In these experiments, a 30-min incubation of OXO with CAMs elicited a typical ESR signal resulting from the CMH trapping, which was measured from cultured CAMs rapidly collected after exposure to OXO. The SOD-inhibitable fraction of the signal, specifically reflecting extracellular O2
production, was compared. Figure 3A depicts representative changes in SOD-inhibitable ESR spectrometric curve recorded under control conditions and after treatment of cells with OXO (80 µM) or ANG II (100 nM). Summarized data from these experiments showed that both OXO and ANG II significantly increased production of O2
outside CAMs (Fig. 3B). At 10 min, a more than threefold increase in extracellular O2
production was observed in these ANG II- or OXO-treated CAMs.
Effects of NAD(P)H oxidase inhibitors on OXO-induced O2
production.
To determine whether the O2
production increase was derived from NAD(P)H oxidase, we examined the effects of two general NAD(P)H oxidase inhibitors, DPI or apocynin, on O2
levels inside and outside CAMs during OXO stimulation using fluorescent microscopic imaging technique. It was found that incubation of CAMs with DPI (50 µM) significantly blocked the maximal increase in intracellular and extracellular O2
levels induced by OXO by 76% and 37%, respectively. It should be noted that the early response of O2
production to OXO was almost blocked by DPI (Fig. 4A). A similar inhibitory effect of apocynin (100 µM) on OXO-induced O2
production was also observed (Fig. 4B).
Effects of gene silencing of NAD(P)H oxidase subunits on OXO-induced O2
production.
RNA interference experiments were performed as described in our previous studies for anti-sense oligodeoxynucleotides or decoy of transcription factors in different cells (48, 49). The transfection rate of siRNA with liposomes was
70% CAMs as detected by fluorescent microscopy of fluorescein-labeled scrambled, small RNA. In CAMs with Nox1 siRNA transfection, both intracellular and extracellular O2
production as measured by ethidium-DNA fluorescence was significantly less than in CAMs with scrambled, small RNAs (Fig. 5A). However, silencing Nox4 in CAMs only significantly reduced intracellular O2
production, but it had no effect on O2
levels detected outside these Nox4-silenced CAMs (Fig. 5B). When the gene of p47phox subunit was silenced, both intra- and extracellular O2
productions were markedly attenuated (Fig. 5C). However, Nox2 siRNA had no significant effect on intra- or extracellular O2
production induced by OXO (data not shown).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 5. Effects of RNA interference on OXO (80 µM)-induced O2 production inside and outside CAMs as measured by fluorescent microscopic imaging analysis. A: effect of Nox1 small inhibitory RNA (siRNA) or scrambled, small RNA (n = 6 cases). B: effect of Nox4 siRNA or scrambled, small RNA (n = 6 cases). C: effect of p47phox siRNA or scrambled, small RNA (n = 6 cases). *P < 0.05 compared with values obtained from CAMs treated with scrambled, small RNA.
|
|
Effects of exogenous O2
on intracellular NAD(P)H oxidase activity.
In these experiments, X (100 µM)/XO (0.1 mU/ml) was added into the bath solution in the preparation used for extracellular and intracellular O2
assay as shown in Fig. 1 to determine whether exogenous O2
stimulates an activation of intracellular NAD(P)H oxidase. As shown in Fig. 6, X/XO significantly induced O2
production with a pattern similar to that of OXO, namely, rapid increase in extracellular O2
followed by a sustained increase in intracellular O2
(Fig. 6A). This intracellular increase in O2
levels induced by X/XO was significantly attenuated by NAD(P)H oxidase inhibitor DPI (Fig. 6B) or apocynin (Fig. 6C). However, increases in extracellular O2
produced by X/XO were not altered by either DPI or apocynin.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 6. Fluorescent microscopic imaging analysis to simultaneously monitor X/XO-induced O2 production inside and outside single CAMs. A: time-dependent increase in oxidized DHE fluorescence ratio (EtBr/DHE) inside and outside CAMs before and after treatment with X (100 µM)/XO (0.1 mU/ml). B: in the presence of DPI (50 µM), X/XO induced EtBr/DHE signal inside and outside CAMs. C: in the presence of APO (100 µM), X/XO induced EtBr/DHE signal inside and outside CAMs. In AC, n = 6 cases. *P < 0.05 compared with control (at 0 min); #P < 0.05 compared with values obtained outside CAMs.
|
|
Spatiotemporal pattern of ANG II-induced O2
production in CAMs.
These experiments were done to determine whether a more rapid O2
production outside than inside cells also occurs in response to other agonists such as ANG II. As conducted in OXO experiments using the high-speed wavelength-switching technique of fluorescent microscopic imaging, both intracellular and extracellular O2
production were simultaneously monitored. Figure 7A presents a typical 30-min dynamic change in fluorescent images indicating O2
production inside and outside CAMs in response to ANG II. In contrast to the findings that OXO induced an increase in O2
signals outside CAMs more rapidly than inside these cells, ANG II produced a parallel increase in fluorescence intensity both outside and inside the cells. The results are summarized in Fig. 7B, showing that intracellular and extracellular O2
production in response to ANG II was similar in magnitude to that induced by OXO. In the presence of SOD (500 U/ml) and catalase (400 U/ml) outside these cells, ANG II-induced increases in O2
levels both inside and outside cells were completely blocked (Fig. 7C). However, CAT alone had no effect on ANG II-induced increases in O2
levels either inside or outside these cells.
Effects of NAD(P)H oxidase inhibitors on ANG II-induced O2
production.
Similar to the results observed in experiments that used OXO as stimuli, the NAD(P)H oxidase inhibitors DPI (50 µM) and apocynin (100 µM) substantially blocked ANG II (100 nM)-induced increases in intracellular and extracellular O2
levels (Fig. 8). The early-stage increases in O2
production both outside and inside CAMs in response to ANG II were also almost completely abolished.
Effects of gene silencing of NAD(P)H oxidase subunits on ANG II-induced O2
production.
Similar to the results obtained in experiments that used OXO as stimuli, Nox1 siRNA attenuated ANG II-induced increase in extracellular O2
levels in CAMs by 46%, whereas Nox4 siRNA substantially decreased intracellular O2
. Moreover, in the presence of p47phox siRNA, both intra- and extracellular O2
production in these cells in response to ANG II markedly decreased (Fig. 9). These data suggest that siRNAs of different subunits or isoforms of NAD(P)H oxidase have similar blocking action on agonist responses no matter whether OXO or ANG II was used. However, Nox1 and Nox4 seem to have different contributions to extracellular or intracellular O2
production. In additional experiments, Nox2 siRNA was not found to have any significant action on extracellular and intracellular O2
production in response to ANG II (data not shown).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 9. Effects of RNA interference of NAD(P)H oxidase on ANG II-induced O2 production inside and outside CAMs as measured by fluorescent microscopic imaging analysis. A: effect of Nox1 siRNA or scrambled, small RNA (n = 6 cases). B: effect of Nox4 siRNA or scrambled, small RNA (n = 6 cases). C: effect of p47phox siRNA or scrambled, small RNA (n = 6 cases). *P < 0.05 compared with values obtained from CAMs treated with scrambled, small RNA.
|
|
 |
DISCUSSION
|
|---|
Despite overwhelming evidence that NAD(P)H oxidase-derived O2
importantly participates in the regulation of vascular function under physiological conditions and that this enzymatic O2
production from vascular cells is involved in the development of various vascular diseases such as atherosclerosis (53), hypertension, and diabetic vasculopathy (10, 54), the mechanisms activating and regulating the activity of this enzyme are still poorly understood. With a highly sensitive fluorescent imaging technique, the present study analyzed a spatiotemporal pattern of O2
production at the single cell level and demonstrated the NAD(P)H oxidase-associated outward production of O2
in CAMs when these cells were stimulated under a relatively physiological condition by M1 agonist OXO and ANG II. This outward production of O2
was confirmed with a variety of ROS detection methods. It was also found that the spatiotemporal pattern of O2
of CAMs in response to OXO or ANG II was different, in which OXO produced a more rapid increase in O2
levels outside than inside CAMs, whereas ANG II induced a parallel increase in O2
levels both outside and inside these cells. In addition, the present study demonstrated that Nox1 may be the major isoform responsible for the increase in the extracellular O2
level, whereas Nox4 primarily contributes to the increased intracellular O2
level.
It should be noted that the major goal of our study is to determine the role of O2
in the rapid and early vasomotor responses to different agonists. Although many activators can stimulate O2
production, they are usually used to stimulate vascular O2
generation or accumulation for a relatively longer time. On the basis of our previous studies, bovine coronary arteries did not produce vasoconstrictor responses to many agonists such as ANG II, norepinephrine, TNF-
, Fas ligand, and other inflammatory cytokines (56, 57). In preliminary experiments, we tried several vasoconstrictors of bovine coronary arteries, including OXO, U-46619, KCl, and CaCl2, which all caused O2
production. Therefore, OXO was chosen as a prototype agonist of bovine coronary vasoconstrictors, which has been often used in previous studies (14, 27, 47). Although ANG II does not strongly constrict bovine coronary arteries, it was used for comparison with OXO in the present study because it has been extensively used as an NAD(P)H oxidase stimulator.
To study the spatiotemporal pattern of O2
production associated with NAD(P)H oxidase activity, a sensitive and dynamic measurement of O2
both inside and outside cells is needed. By modification of a high-speed wavelength-switching fluorescent microscopic imaging system that we used for simultaneous monitoring of Ca2+ and NO in vascular cells (51) and with the help of Matrigel to trap DNA around CAMs, we developed a highly sensitive imaging method to simultaneously monitor extracellular and intracellular DHE-oxidizing signals, which represent O2
levels. In these experiments, Matrigel as a supportive matrix trapped DNA that is capable of binding to ethidium from oxidation of DHE in solution, and a ratio of ethidium-DNA to DHE fluorescent signals was recorded to represent O2
. This ratiometric assay of O2
levels using DHE was used in our previous study and by others (36, 55); this method increases the sensitivity for O2
detection and avoids an artifact in assays from cell volume changes or contractions during agonist stimulation. By high-speed wavelength switching, extracellular and intracellular signals can be simultaneously recorded. Using this record system, we first found that, in response to M1-receptor activation, extracellular and intracellular O2
signals could be resolved in a time-dependent manner, which was blocked by the presence of SOD and CAT, suggesting that this assay can be used for dynamic analyses of O2
production. In particular, it seems that the system is sensitive for detecting O2
production of a single cell at an early stage of stimulation by M1 agonist. In previous studies, although DHE-based assay was used for a variety of samples or preparations for detection of intracellular O2
, a dynamic observation of O2
production within a short time period of 10 or 30 min could not be resolved (2). More importantly, simultaneously monitoring of O2
increases inside and outside CAMs in response to M1 agonist provides an important tool to study the orientation of O2
production in these cells and to explore the triggering mechanism of redox signaling in the regulation of vascular function. For example, the finding of a relatively early SOD-blockable increase in O2
levels outside CAMs may suggest that outward O2
production in the early stage of M1-receptor activation triggers intracellular increases in O2
because addition of cell membrane-impermeable SOD outside cells blocked increases in O2
signals both outside and inside CAMs. In this regard, O2
may serve as an autocrine to activate some membrane receptors or different signaling pathways to result in O2
production from intracellular sources (45). In addition, O2
can also enter the cells through its channels or other membrane carriers and activate intracellular O2
production through different enzymes such as NAD(P)H oxidase. Recent studies have already demonstrated that NAD(P)H oxidase could be activated by O2
, leading to a positive feedback response (31). In the present study, we also tested whether extracellular O2
stimulates NAD(P)H oxidase activation. It was found that addition of X/XO in the bath solution significantly induced extracellular and intracellular O2
production with a pattern similar to that of OXO, which was markedly attenuated by NAD(P)H oxidase inhibitors. This indicates that O2
from X/XO outside these cells at least partially exerts its action through enhanced intracellular O2
production. This stimulatory action of O2
on intracellular NAD(P)H oxidase may explain previous findings from our laboratory and by others that extracellular addition of the O2
-producing system largely increased intracellular O2
(38, 58). Given the ionic characteristics of O2
, the entry of O2
into cells should be relatively difficult. Therefore, increased intracellular O2
under this condition would be primarily produced from activation of intracellular NAD(P)H oxidase. In addition, this redox activation of NAD(P)H oxidase by another ROS, H2O2, has also been reported recently (31).
There was a concern that the temporal difference between increased O2
induced by M1 agonist inside and outside cells may be due to different trapping or trafficking efficiency of intra- or extracellular O2
, since the DHE-oxidizing product ethidium needs to bind to DNA. However, some of our results demonstrated that this is not the case. First, we used another indicator, H2DCFDA, which directly detects O2
metabolite via SOD (H2O2) in cytoplasma and found a pattern of changes in intracellular and extracellular redox signals similar to what was observed with DHE as the indicator inside and outside CAMs. Second, when another agonist (ANG II) was used, a parallel increase in O2
inside and outside these cells was observed. This is different from the pattern exhibited during M1-receptor activation. These results further confirm that the spatiotemporal patterns of O2
production observed by this monitoring system represent different responses of intracellular and extracellular production, rather than the artifact of the assays.
One of the major goals in the present study is to illustrate the production of O2
outside CAMs because there is no direct evidence showing that vascular myocytes could produce O2
toward the outside of these cells, despite this orientation of O2
production being assumed (4, 25). In addition to fluorescent imaging analysis, the present study used three other different methods to demonstrate that CAMs could enzymatically produce O2
toward the outside of these cells. These methods included microscopic detection of NBT staining, confocal microscopy analysis of extracellularly trapped H2O2 by Matrigel, and ESR measurements. It was found that M1 agonist OXO induced formation of insoluble formazin-NBT precipitation on the surface of CAMs. This dye was widely used to determine activation of NAD(P)H oxidase in phagocytes for O2
production during respiratory burst (39). Using confocal microscopy, we observed an increase in green fluorescence of OxyBURST H2HFF BSA dye around CAMs in response to OXO, which indicates extracellular H2O2 increase (8). Because this BSA conjugate cannot enter cells, this detected green fluorescence represents extracellular ROS. Although this assay did not directly detect O2
levels, the increase in H2O2 amount outside these cells under this short-term OXO stimulation is undoubtedly indicative of O2
production or accumulation, since there is evidence that inhibition of NAD(P)H oxidase could attenuate the enhancement of this extracellular fluorescence derived from the BSA-H2HFF conjugates. Finally, we performed ESR spectrometry to further confirm OXO-induced O2
production outside these CAMs. In these experiments, SOD-sensitive components of ESR spectrometric signals in cell suspensions were analyzed to represent extracellular O2
. Given the high specificity of ESR trapping assay in detecting O2
, these experiments attempted to confirm that O2
is detectable outside CAMS when they are stimulated by agonists. Although this ESR spectrometric assay could not use a single cell to detect O2
level (9), it is important that the signal highly specific to O2
can be detected outside CAMs, which can further support the view that an outward production of O2
occurs in these cells in response to M1-receptor activation. The results showed that the SOD-sensitive ESR signal was significantly increased when CAMs were stimulated by OXO. Taken together, all four different assays that we used in the present study consistently demonstrated that there is a mechanism by which O2
is produced toward the outside of CAMs when their M1 receptors are activated. This outwardly produced O2
may play an autocrine or paracrine role in the regulation of vascular function.
To determine the contribution of NAD(P)H oxidase to increased extra- and intracellular O2
production, we first examined the effects of two widely used NAD(P)H oxidase inhibitors (DPI and apocynin) on O2
increases induced by OXO. Fluorescent imaging analysis demonstrated that, in the presence of either DPI or apocynin, OXO-induced increases in O2
levels both outside and inside CAMs were substantially blocked. In particular, increased intracellular O2
under this condition was completely abolished. This suggests that both extra- and intracellular O2
are associated with the activity of NAD(P)H oxidase. Next, we examined the effects of RNA interference by specific siRNA of different subunits of NAD(P)H oxidase. It was found that introduction of Nox1 or p47phox-specific siRNA significantly attenuated OXO-induced increases in O2
production both inside and outside CAMs. However, when these cells were transferred with Nox4 siRNA, only the intracellular increase in O2
was reduced. This Nox4 RNA interference had no effect on increased production of extracellular O2
. These results provide evidence that both extracellular and intracellular O2
production are associated with NAD(P)H oxidase activity and that different mechanisms or isoforms of NAD(P)H oxidase may mediate O2
production inside or outside these arterial myocytes. It seems that Nox1 rather than Nox4 is primarily responsible for the production of extracellular O2
, since Nox4 siRNA and Nox2 could not block the increase in O2
outside CAMs. Although the attenuation of intra- and extracellular increases in O2
by Nox1 siRNA seems to indicate that this isoform of NAD(P)H oxidase contributes to the production of O2
both outside and inside these cells, as discussed above, the increase in intracellular O2
via Nox1 may not be directly toward the inside of these cells. It is possible that, in CAMs, Nox1 is activated by stimulation of M1 receptors and then O2
, as an autocrine or paracrine, may lead to activation of an intracellular NAD(P)H oxidase, which may be Nox4 because Nox2 siRNA had no effect on increases in intracellular O2
. Several previous reports have indicated that Nox4 is a primary isoform responsible for intracellular O2
production (44, 52). In this regard, Nox1 has been shown to be enriched in the membrane fraction and Nox4 predominantly in the intracellular compartments of vascular myocytes (20, 52). It is known that Nox1 is membrane bound and uses intracellular NADPH or NADH as substrate to produce O2
. Although there is a possibility that an extracellular NAD(P)H oxidase may be present (37), detectable O2
outside CAMs in our preparations is mainly from an enzyme located inside cells because extracellular addition of NADPH (10 mM) was not found to induce any changes in O2
production both inside and outside these cells. There are many possible mechanisms by which extracellular O2
may further activate intracellular NAD(P)H oxidase to produce intracellular O2
. For example, extracellular O2
has been reported to activate PKC and thereby result in phosphorylation of p47phox, thus activating intracellular NAD(P)H (4). In other studies, extracellular O2
was found to alter the activity of cell membrane ion channels such as inhibition of K+ channels or activation of Ca2+ channels and increase intracellular Ca2+ concentrations. Because NAD(P)H oxidase activity is Ca2+ sensitive, increased Ca2+ would activate NAD(P)H oxidase activity (1). In addition, extracellular O2
could be converted into H2O2, which can easily enter the cells to directly or through some other pathway activate NAD(P)H oxidase, resulting in intracellular O2
production (31).
Another important finding of the present study was that ANG II stimulates CAMs to produce O2
outside and inside CAMs in parallel, which is different from that observed when these cells were stimulated by OXO. This parallel increase in extracellular and intracellular O2
production in response to ANG II could be blocked or substantially attenuated by either SOD plus CAT or NAD(P)H oxidase inhibitors, suggesting that NAD(P)H oxidase is also responsible for the O2
production both outside and inside these arterial myocytes during ANG II stimulation. It is unclear why ANG II increases extracellular and intracellular O2
production in parallel, whereas OXO increases O2
production earlier extracellularly than intracellularly. One possible mechanism may be associated with their postreceptor activating pathways. In this regard, ANG II has been demonstrated to activate NAD(P)H oxidase through phosphorylation of its subunits such as p47phox (28). Given no specificity of this phosphorylation process to cellular compartments, NAD(P)H oxidase could be activated no matter where this enzyme is primarily located, either on the cell membrane or in intracellular compartments such as the sarcoplasmic reticulum (52), lysosomes (8), and even cytosol (17). Therefore, a parallel increase in extracellular and intracellular O2
could be observed when ANG II was added. However, the M1 agonist OXO may activate NAD(P)H oxidase through changes in cell membrane electrical feature such as depolarization of membrane, rather than phosphorylation. NAD(P)H oxidase electrogenic activation has been reported in some other cells (11, 29). This membrane electrogenic activation may lead to a rapid production of O2
toward the outside of cells followed by activation of intracellular NAD(P)H oxidase through the autocrine action of O2
or its metabolites outside these cells. Taken together, our results suggest that membrane-bound and intracellular organelle NAD(P)H oxidases could be activated with a temporal difference when arterial myocytes receive different agonistic stimuli.
It should be noted that NAD(P)H oxidase activation may not require p47phox in some other cell types. For example, Martyn et al. (33) reported that this phox subunit is not needed for NAD(P)H oxidase activation in epithelial cell. We also found that, in renal mesangial cells, p47phox translocation from cytosol to membrane does not occur during different stimuli (50). However, this p47phox translocation is strongly required by bovine coronary endothelial cells (59). In VSMCs, considerable evidence shows that p47phox is needed during activation of NAD(P)H oxidase (24). Our results using p47phox siRNA demonstrate that both intracellular and extracellular O2
productions require p47phox.
In summary, the present study demonstrated the following. 1) M1-receptor activation stimulated O2
production both outside and inside CAMs with a spatiotemporal pattern of more rapid extracellular increase in O2
levels followed by a slow increase in intracellular O2
levels. This O2
production induced by M1 agonist is due to NAD(P)H oxidase activation. 2) Nox1 was found to primarily contribute to extracellular O2
production, whereas Nox4 is a dominant enzyme responsible for intracellular O2
generations. 3) ANG II also stimulated both extra- and intracellular O2
production, but the spatiotemporal pattern was different from that observed during M1 agonist stimulation, which increases O2
levels outside and inside CAMs in parallel. This difference of the spatiotemporal pattern of O2
production in CAMs in response to different agonists may be related to different activating mechanism of NAD(P)H oxidase when these cells receive stimuli. It is concluded that, in response to different agonists, CAMs exhibit different spatiotemporal patterns of O2
production, which is associated with NAD(P)H oxidase activation. Extracellular O2
production through Nox1 on the cell membrane represents an autocrine or paracrine model by which O2
may exert an important role in autocrine regulation or cell-cell communication in coronary arteries.
 |
GRANTS
|
|---|
This study was supported by National Heart, Lung, and Blood Institute Grants HL-57244, HL-75316, and HL-70726.
 |
FOOTNOTES
|
|---|
Address for reprint requests and other correspondence: P.-L. Li, Dept. of Pharmacology and Toxicology, Medical College of Virginia, 410 North 12th St., Richmond, VA 23298 (e-mail: pli{at}vcu.edu)
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
 |
REFERENCES
|
|---|
- Ameziane-El-Hassani R, Morand S, Boucher J-L, Frapart Y-M, Apostolou D, Agnandji D, Gnidehou S, Ohayon R, Noel-Hudson M-S, Francon J, Lalaoui K, Virion A, Dupuy C. Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity. J Biol Chem 280: 3004630054, 2005.[Abstract/Free Full Text]
- Becker LB, vanden Hoek TL, Shao ZH, Li CQ, Schumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol Heart Circ Physiol 277: H2240H2246, 1999.[Abstract/Free Full Text]
- Beckman J, Minor R Jr, White C, Repine J, Rosen G, Freeman B. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem 263: 68846892, 1988.[Abstract/Free Full Text]
- Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 65: 1627, 2005.[Abstract/Free Full Text]
- Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 96: 818822, 2005.[Abstract/Free Full Text]
- Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 55: 253258, 1994.[Abstract]
- Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 102: 90569061, 2005.[Abstract/Free Full Text]
- Chen CS. Phorbol ester induces elevated oxidative activity and alkalization in a subset of lysosomes. BMC Cell Biol 3: 21, 2002.[CrossRef][Medline]
- Cherednichenko G, Zima AV, Feng W, Schaefer S, Blatter LA, Pessah IN. NADH oxidase activity of rat cardiac sarcoplasmic reticulum regulates calcium-induced calcium release. Circ Res 94: 478486, 2004.[Abstract/Free Full Text]
- Cotter MA, Cameron NE. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci 73: 18131824, 2003.[CrossRef][ISI][Medline]
- DeCoursey TE, Morgan D, Cherny VV. The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels. Nature 422: 531534, 2003.[CrossRef][Medline]
- Di Wang H, Pagano PJ, Du Y, Cayatte AJ, Quinn MT, Brecher P, Cohen RA. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 82: 810818, 1998.[Abstract/Free Full Text]
- Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85: 632639, 1990.[ISI][Medline]
- Ge ZD, Zhang DX, Chen YF, Yi FX, Zou AP, Campbell WB, Li PL. Cyclic ADP-ribose contributes to contraction and Ca2+ release by M1 muscarinic receptor activation in coronary arterial smooth muscle. J Vasc Res 40: 2836, 2003.[CrossRef][ISI][Medline]
- Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 11411148, 1994.[Abstract/Free Full Text]
- Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494501, 2000.[Abstract/Free Full Text]
- Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, Ahmad M, Edwards J, Wolin MS. Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol 288: H13H21, 2005.[Abstract/Free Full Text]
- Hancock JT, Maly FE, Jones OT. Properties of the superoxide-generating oxidase of B-lymphocyte cell lines. Determination of Michaelis parameters. Biochem J 262: 373375, 1989.[ISI]